JeffreyMKaplanMD
Neurology • Roeland Park, KSHeadache, Neuroimmunology/Multiple Sclerosis
Neurologist in Roeland Park, Kansas
Dr. Kaplan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5675 Roe Blvd
Suite 260
Roeland Park, KS 66205Phone+1 913-632-2680Fax+1 913-632-2681
Summary
- Jeffrey Kaplan, MD is a highly experienced neurologist based in Overland, Kansas. He has undertaken his medical education and training at reputable institutions such as the University of Iowa Hospitals and Clinics and University of Kansas School of Medicine. Dr. Kaplan has special expertise in general neurology, dementia, neuroimmunology including multiple sclerosis, sleep medicine and working as a neurohospitalist. He has numerous publications related to his areas of expertise and is particularly recognized in the field of neuroimmunology. Notably, he received the CMS Meaningful Use Stage 1 Certification in 2012-2013.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Neurology, 1988 - 1991- University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 1987 - 1988
University of Kansas School of MedicineClass of 1987
Certifications & Licensure
KS State Medical License 2003 - 2025
MO State Medical License 1991 - 2006
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design.Peter V Sguigna, Rehana Z Hussain, Annette Okai, Kyle M Blackburn, Lauren Tardo
Therapeutic Advances in Neurological Disorders. 2024-01-01 - 1 citationsActharGel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.Jeffrey Kaplan, Anca Askanase, David Chu, Abdul Abdellatif, Dhiman Basu
Clinical Drug Investigation. 2023-10-01 - 2 citationsRepository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse.Jeffrey Kaplan, Tamara Miller, Matthew L. Baker, Bryan Due, Enxu Zhao
Neurodegenerative Disease Management. 2021-12-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
